ProKidney Corp.
PROK
$2.28
$0.031.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.05% | -32.35% | -76.30% | -273.23% | -63.06% |
| Total Depreciation and Amortization | 12.58% | 15.35% | 45.19% | 37.35% | 47.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.42% | 26.10% | 23.85% | 10.96% | 36.27% |
| Change in Net Operating Assets | 584.01% | 74.86% | 119.16% | 349.55% | -104.57% |
| Cash from Operations | 9.05% | 17.96% | 14.59% | 4.78% | -22.98% |
| Capital Expenditure | -116.18% | -389.31% | -18.23% | -1,522.71% | 91.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 143.18% | -25.78% | -50.43% | 143.06% | -18,114.02% |
| Cash from Investing | 135.55% | -35.02% | -51.56% | 115.73% | -187.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 135.71% | -7.69% | 7.69% | -7.69% | -7.69% |
| Issuance of Common Stock | 77.99% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 78.66% | -100.01% | 7.69% | 101.29% | 34,376.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 109.76% | -109.89% | -105.54% | 93.14% | -104.01% |